Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -68.72% vs 2.09% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
No Fixed Assets in the last few periods;
Investments
YoY Growth in year ended Mar 2025 is -7.18% vs 0.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is NA vs NA in Mar 2024
Compare Balance Sheet Results of Johnson Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
55.00
5.76
49.24
854.86%
Share Warrants & Outstandings
Total Reserve
1.17
6.93
-5.76
-83.12%
Shareholder's Funds
56.17
12.69
43.48
342.63%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.61
4.15
-3.54
-85.30%
Secured Loans
0.61
4.15
-3.54
-85.30%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.00
-0.49
0.49
100.00%
Other Long Term Liabilities
0.00
1.30
-1.30
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.61
4.96
-4.35
-87.70%
Current Liabilities
Trade Payables
0.00
0.08
-0.08
-100.00%
Other Current Liabilities
1.15
5.47
-4.32
-78.98%
Short Term Borrowings
0.00
0.26
-0.26
-100.00%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
1.15
5.81
-4.66
-80.21%
Total Liabilities
57.93
23.45
34.48
147.04%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.00
2.02
-2.02
-100.00%
Less: Accumulated Depreciation
0.00
1.10
-1.10
-100.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.00
0.91
-0.91
-100.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
42.29
0.00
42.29
0.00%
Long Term Loans & Advances
14.27
0.64
13.63
2,129.69%
Other Non Current Assets
0.00
0.06
-0.06
-100.00%
Total Non-Current Assets
56.56
1.62
54.94
3,391.36%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.00
0.00
0.00
0.00%
Sundry Debtors
0.00
16.39
-16.39
-100.00%
Cash and Bank
0.01
2.17
-2.16
-99.54%
Other Current Assets
1.35
1.69
-0.34
-20.12%
Short Term Loans and Advances
0.00
1.58
-1.58
-100.00%
Total Current Assets
1.36
21.84
-20.48
-93.77%
Net Current Assets (Including Current Investments)
0.21
16.03
-15.82
-98.69%
Total Current Assets Excluding Current Investments
1.36
21.84
-20.48
-93.77%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
57.93
23.45
34.48
147.04%
Contingent Liabilities
0.00
5.35
-5.35
-100.00%
Total Debt
0.61
4.40
-3.79
-86.14%
Book Value per share (adjusted)
1.02
22.03
-21.01
-95.37%
Annual - Borrowings
Borrowings 0.61 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -68.72% vs 2.09% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
No Fixed Assets in the last few periods
No Fixed Assets in the last few periods;
Annual - Investments
Investments 42.29 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -7.18% vs 0.00% in Mar 2024
Annual - Current Assets
Current Assets 1.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is NA vs NA in Mar 2024






